Cefmenoxime

Jump to: navigation, search
220px
Cefmenoxime
Systematic (IUPAC) name
(6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-
2-methoxyimino-acetyl]amino}-3-[(1-methyltetrazol-
5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]
oct-2-ene-2-carboxylic acid
Identifiers
CAS number 65085-01-0
ATC code J01DD05
PubChem 5361486
DrugBank APRD00851
Chemical data
Formula C16H17N9O5S3 
Mol. mass 511.562 g/mol
Pharmacokinetic data
Bioavailability 100% (given IM)
Protein binding 50% to 70%
Metabolism Negligible
Half life 1 hour
Excretion Renal, unchanged
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes Intramuscular, intravenous

WikiDoc Resources for

Cefmenoxime

Articles

Most recent articles on Cefmenoxime

Most cited articles on Cefmenoxime

Review articles on Cefmenoxime

Articles on Cefmenoxime in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cefmenoxime

Images of Cefmenoxime

Photos of Cefmenoxime

Podcasts & MP3s on Cefmenoxime

Videos on Cefmenoxime

Evidence Based Medicine

Cochrane Collaboration on Cefmenoxime

Bandolier on Cefmenoxime

TRIP on Cefmenoxime

Clinical Trials

Ongoing Trials on Cefmenoxime at Clinical Trials.gov

Trial results on Cefmenoxime

Clinical Trials on Cefmenoxime at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cefmenoxime

NICE Guidance on Cefmenoxime

NHS PRODIGY Guidance

FDA on Cefmenoxime

CDC on Cefmenoxime

Books

Books on Cefmenoxime

News

Cefmenoxime in the news

Be alerted to news on Cefmenoxime

News trends on Cefmenoxime

Commentary

Blogs on Cefmenoxime

Definitions

Definitions of Cefmenoxime

Patient Resources / Community

Patient resources on Cefmenoxime

Discussion groups on Cefmenoxime

Patient Handouts on Cefmenoxime

Directions to Hospitals Treating Cefmenoxime

Risk calculators and risk factors for Cefmenoxime

Healthcare Provider Resources

Symptoms of Cefmenoxime

Causes & Risk Factors for Cefmenoxime

Diagnostic studies for Cefmenoxime

Treatment of Cefmenoxime

Continuing Medical Education (CME)

CME Programs on Cefmenoxime

International

Cefmenoxime en Espanol

Cefmenoxime en Francais

Business

Cefmenoxime in the Marketplace

Patents on Cefmenoxime

Experimental / Informatics

List of terms related to Cefmenoxime


Cefmenoxime is a third-generation cephalosporin antibiotic.

External links

  • DDB 30892
  • Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Deguchi K, Oda S, Tanaka S, Nakane Y, Fukumoto T (1995). "Antibacterial activities of cefmenoxime against recent fresh clinical isolates from patients in sinusitis". Jpn J Antibiot 48 (5): 602-9. PMID 7637194.
  • Paladino J, Fell R (1994). "Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia.". Ann Pharmacother 28 (3): 384-9. PMID 8193431.
  • Duncker G, Reich U, Krausse R (1994). "Cefmenoxime in corneal organ culture.". Ophthalmologica 208 (5): 262-6. PMID 7816419.
th:เซฟมีนอกซิม



Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox